|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total costs and expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Net loss per share attributable to Class A, Class B, and Class C common stockholders (Note 3): | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average shares used in computation of net loss per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
